DNA methiylation signatures in MS twins

A forum to discuss research on the origins of MS and its development.

DNA methiylation signatures in MS twins

Postby frodo » Tue Aug 07, 2018 6:57 am

DNA methylation signatures of a large cohort monozygotic twins clinically discordant for multiple sclerosis



Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system with a modest concordance rate in monozygotic twins that strongly argues for involvement of epigenetic factors. We observe in 45 MS discordant monozygotic twins highly similar peripheral blood mononuclear cell-based methylomes. However, a few MS-associated differentially methylated positions (DMP) were identified and validated, including a region in the TMEM232 promoter and ZBTB16 enhancer. In CD4+ T cells we observed an MS-associated differentially methylated region in FIRRE.

In addition, many regions showed large methylation differences in individual pairs, but were not clearly associated with MS. Furthermore, epigenetic biomarkers for current interferon-beta treatment were identified, and extensive validation revealed the ZBTB16 DMP as a signature of prior glucocorticoid treatment. Altogether, our study represents an important reference for epigenomic MS studies. It identifies new candidate epigenetic markers, highlights treatment effects and genetic background as major confounders, and argues against some previously reported MS-associated epigenetic candidates.
User avatar
Family Elder
Posts: 1152
Joined: Wed Dec 02, 2009 3:00 pm


Return to MS Etiology and Pathogenesis

Who is online

Users browsing this forum: No registered users

Contact us | Terms of Service